Approval for the addition of the antibiotic cefotaxime at concentrations of 0.06, 0.25, 0.5 and 1 micrograms/ml to the vitek(r) 2 s. pneumoniae susceptibility test system.  The device will be marketed under the trade name vitek(r) 2 s. pneumoniae susceptibility test cards for use in the vitek 2 system and is indicated for use for the susceptibility testing of streptococcus pneumoniae to cefotaxime in the range of <=0.06 to >=4 micrograms/ml.